好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2006 Annual Meeting | Poster Session 06

Thursday 04/06/06
03:00 PM - 07:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Aging and Dementia, Movement Disorders, MS and Related Diseases, Neuro-oncology, Epilepsy, Epilepsy/Clinical Neurophysiology (EEG), Cerebrovascular Disease and Interventional Neurology, Clinical Neurophysiology, Muscle Disease/Neuromuscular Junction, Headache and Pain
No CME available
Event Timeline
03:00 PM - 07:00 PM Abstract 001 - Magnetic Resonance Imaging Features of Histologically Documented Cerebral Radiation Necrosis
03:00 PM - 07:00 PM Abstract 002 - Predicting the Histopathological Grade of Cerebral Gliomas Using High b-Value Diffusion-Weighted MR Imaging
03:00 PM - 07:00 PM Abstract 003 - Surgical Planning for Brain Tumor Patients with Magnetic Source Imaging
03:00 PM - 07:00 PM Abstract 004 - Serum Markers for Patients with Malignant Gliomas
03:00 PM - 07:00 PM Abstract 005 - Investigating the Cancer Stem Cell Hypothesis in Human Glioblastomas: Co-Localization of ATF5 and CD133 Identifies a Subpopulation of Progenitor-Like Cells
03:00 PM - 07:00 PM Abstract 006 - A Multicenter Study of Prognosis and Treatment of Adult Brain Ependymal Tumors
03:00 PM - 07:00 PM Abstract 007 - Comparison of Initial Treatment Strategies for Anaplastic Oligodendroglioma (AO)
03:00 PM - 07:00 PM Abstract 008 - Combined Regimen of Temozolomide and Liposomal Pegylated Doxorubicin in Glioblastoma - Toxicity and Efficacy
03:00 PM - 07:00 PM Abstract 009 - Phase I Analysis of Systemic Interferon Alpha Utilized with Gliadel in Subjects with Recurrent Glioblastoma Multiforme (GBM)
03:00 PM - 07:00 PM Abstract 010 - Intra-Arterial Carboplatin and Oral Temozolomide for the Treatment of Progressive Metastatic Brain Tumors
03:00 PM - 07:00 PM Abstract 011 - A Case of Prospective Use of Carboksypeptidase G2 Rescue for Brain Lymphoma Treated with High-Dose Methotrexate
03:00 PM - 07:00 PM Abstract 012 - Salvage Whole Brain Radiotherapy (WBRT) for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL)
03:00 PM - 07:00 PM Abstract 013 - A Pilot Study of Radiolabeled Indium-111 and Yttrium-90 Ibritumomab Tiuxetan in Primary CNS Lymphoma (PCNSL)
03:00 PM - 07:00 PM Abstract 014 - Bcl-6 Expression Predicts Improved Relapse-Free Survival in Primary Central Nervous System Lymphoma
03:00 PM - 07:00 PM Abstract 015 - Leptomeningeal Spread and Lymphomatosis as Presenting Symptom of Primary T- Cell CNS Lymphoma
03:00 PM - 07:00 PM Abstract 016 - A Phase I Study of Intraventricular Injection of I-131 Sodium Iodide in Patients with Leptomeningeal Metastasis (LM)
03:00 PM - 07:00 PM Abstract 017 - Interaction between Route of Intra-CSF Chemotherapy Administration and Efficacy of Therapy in Patients with Neoplastic Meningitis
03:00 PM - 07:00 PM Abstract 018 - A Feasibility Study of Intraventricular Methotrexate by Continuous Infusion Using the Synchromed Infusion System for Leptomeningeal Metastasis
03:00 PM - 07:00 PM Abstract 019 - Potential Efficacy of Somatostatin for Treatment of Recurrent Meningiomas
03:00 PM - 07:00 PM Abstract 020 - Intensity-Modulated Radiation Therapy (IMRT) for Newly Diagnosed and Recurrent Intracranial Meningiomas: The Cleveland Clinic Foundation Experience
03:00 PM - 07:00 PM Abstract 021 - Limbic Encephalitis (LE): Clinical and Immunological Phenotypes of 35 Patients
03:00 PM - 07:00 PM Abstract 022 - Severe Hypokinesis Caused by Anti-Ma2 Encephalitis Associated with Bilateral Carcinoma In Situ of the Testis
03:00 PM - 07:00 PM Abstract 023 - Paraneoplastic Neurological Syndromes from the PNS Euronetwork Database
03:00 PM - 07:00 PM Abstract 025 - Anti-Neuronal Nuclear Antibody Type 4 (ANNA-4), a Novel Paraneoplastic Marker of Small Cell Lung Carcinoma (SCLC)
03:00 PM - 07:00 PM Abstract 026 - Radiation Lumbosacral Plexopathy: A Warfarin-Responsive Neuropathy?
03:00 PM - 07:00 PM Abstract 027 - Primary Spinal Melanoma: A Case Report and Review of the Literature
03:00 PM - 07:00 PM Abstract 028 - Neurocutaneous Melanosis Presenting with New-Onset Type 1 Diabetes
03:00 PM - 07:00 PM Abstract 029 - Seizure as the Presenting Symptom in Primary and Metastatic Brain Tumors
03:00 PM - 07:00 PM Abstract 030 - Two MMR Mutations Associated with Turcot Syndrome
03:00 PM - 07:00 PM Abstract 031 - Incidence of Multifocal Lesions in Malignant Glioma as Detected by MRI
03:00 PM - 07:00 PM Abstract 032 - QOLIE Scores Are Not Affected by Obstructive Sleep Apnea in Patients with Intractable Epilepsy
03:00 PM - 07:00 PM Abstract 033 - Seizure, Maternal and Fetal Outcome in Women with Neurocysticercosis and Pregnancy - Observations from Indian Registry for Epilepsy and Pregnancy
03:00 PM - 07:00 PM Abstract 034 - Some Relationships among Ovulation Rates, Menstrual Cycle Intervals and Seizure Frequency: Preliminary Data Analysis in a Prospective Multicenter Investigation
03:00 PM - 07:00 PM Abstract 035 - Women's Knowledge and Perceptions about Epilepsy and Antiepileptic Drugs
03:00 PM - 07:00 PM Abstract 036 - Differences between Patients with Psychogenic, Non-Epileptic Attacks and Electrical Seizures as Measured by the Symptom Checklist-90-Revised
03:00 PM - 07:00 PM Abstract 037 - Patterns of Injury in Individuals with Epilepsy: The Ohio Medicaid Population
03:00 PM - 07:00 PM Abstract 038 - In Patients with Hippocampal Abnormalities on MRI, Do the Ictal and Interictal EEG Patterns Matter?
03:00 PM - 07:00 PM Abstract 039 - Postictal but Not Interictal Hemispatial Neglect in Patients with Seizures of Lateralized Onset
03:00 PM - 07:00 PM Abstract 040 - Determinants of the Epilepsy Treatment Gap in Developing Countries
03:00 PM - 07:00 PM Abstract 041 - Non-Convulsive Status Epileticus: Predictors and Prognosis in 42 Patients in the Intensive Care Unit
03:00 PM - 07:00 PM Abstract 042 - Seizure Risk in Patients with ADHD Treated with Atomoxetine
03:00 PM - 07:00 PM Abstract 043 - Seizure Type, Sex, and Age Are Predictors of Positive Response to Intravenous Gamma Globulin (IVIG) in Intractable Epilepsy
03:00 PM - 07:00 PM Abstract 044 - Post Ictal Headaches (PIH) in Children and Adolescents (C/A)
03:00 PM - 07:00 PM Abstract 045 - Value of Post-Ictal Breathing Pattern in Differential Diagnosis of Generalized Tonic-Clonic Seizures and Non-Epileptic Convulsive Seizures
03:00 PM - 07:00 PM Abstract 046 - Patterns of Cognitive Performance on the Alzheimer's Disease Assessment Scale-Cognition Differentiate between Alzheimer's Disease and Vascular Dementia
03:00 PM - 07:00 PM Abstract 047 - Alzheimer's Disease in Patients with Down's Syndrome: Can Death Be Predicted?
03:00 PM - 07:00 PM Abstract 048 - Outcomes of Immunosuppressive Therapy in A[beta]-Associated Cerebral Vasculitis
03:00 PM - 07:00 PM Abstract 050 - CSF Albumen Index, a Marker of Blood-Brain Barrier Integrity, Is Abnormal and Highly Reproducible in a Minority of Subjects with Alzheimer's Disease
03:00 PM - 07:00 PM Abstract 051 - Contributions of the Frontal Lobes on Executive Functioning Test Performance
03:00 PM - 07:00 PM Abstract 052 - Chronic Psychological Stress and APOE-e4 Genotype Interact To Influence Cortisol and Memory
03:00 PM - 07:00 PM Abstract 053 - The Effect of Memantine on Distinct Behavior Syndromes in Moderate to Severe AD Patients
03:00 PM - 07:00 PM Abstract 054 - Progression to Dementia and Recovery to Normal Functioning in Cognitive-Impairment-No-Dementia (CIND) Have Unique Neuropsychological Predictors
03:00 PM - 07:00 PM Abstract 056 - Predicting Progression of Alzheimer's Disease
03:00 PM - 07:00 PM Abstract 057 - Treatment of Severe Alzheimer's Disease with Donepezil: Results from a 24-Week, Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
03:00 PM - 07:00 PM Abstract 058 - Efficacy and Safety of MPC-7869 (R-Flurbiprofen), a Selective Ab42-Lowering Agent, in Mild Alzheimer's Disease (AD): Results of a 12-Month Phase 2 Trial and 1-Year Follow-On Study
03:00 PM - 07:00 PM Abstract 059 - Efficacy of Memantine on Cognition in Mild to Moderate Alzheimer's Disease
03:00 PM - 07:00 PM Abstract 062 - Analysis of Plasma Amyloid Beta in Posterior Cortical Atrophy (PCA)
03:00 PM - 07:00 PM Abstract 063 - Construct Validity of the Telephone-Modified Mini-Mental State Examination (t-3MS)
03:00 PM - 07:00 PM Abstract 064 - A Double Dissociation between Verbal Memory and Visual-Spatial Executive Function in Patients with Dementia with Lewy Bodies and Alzheimer's Disease
03:00 PM - 07:00 PM Abstract 065 - Differences in Memory Performance between Autopsy-Defined Vascular and Alzheimer Cases
03:00 PM - 07:00 PM Abstract 066 - Clinical Impact of Microbleed in Subcortical Vascular Dementia
03:00 PM - 07:00 PM Abstract 067 - Treatment of Alzheimer's Disease with Intravenous Immunoglobulins
03:00 PM - 07:00 PM Abstract 068 - Impact of a Condensed Protocol for Disclosing Genetic Susceptibility for Alzheimer's Disease: The REVEAL Study
03:00 PM - 07:00 PM Abstract 069 - Efficacy of Donepezil on Secondary End Points in a Randomized, Double-Blind, Placebo-Controlled Study in Severe Alzheimer's Disease
03:00 PM - 07:00 PM Abstract 070 - Functional, Global and Cognitive Decline Correlates to Accumulation of Alzheimer's Pathology
03:00 PM - 07:00 PM Abstract 071 - The Effect of Donepezil on Memory in Older Normal Subjects
03:00 PM - 07:00 PM Abstract 072 - Clinical Differences between Patients with Early and Late Onset Alzheimer's Disease
03:00 PM - 07:00 PM Abstract 073 - Psychometric Properties of the 3MS and MMSE in the Oldest-Old: Sensitivity and Specificity
03:00 PM - 07:00 PM Abstract 074 - Hormone Therapy Use in Midlife Does Not Influence Episodic Memory: Prospective Analyses after Natural Menopause
03:00 PM - 07:00 PM Abstract 075 - The Validity and Reliability of the AD8
03:00 PM - 07:00 PM Abstract 076 - Cognitive Profile in the Syndrome of Hydrocephalus in Young and Middle-Aged Adults (SHYMA)
03:00 PM - 07:00 PM Abstract 077 - Neurohormonal Activation in Ischemic Stroke: Effects of Acute Phase Disturbances on Long-Term Mortality
03:00 PM - 07:00 PM Abstract 078 - Significance of Serum N-Terminal pro-B-Type Natriuretic Peptide in Patients with Acute Cerebrovascular Diseases
03:00 PM - 07:00 PM Abstract 079 - Relations to Plasma Fibrinogen Concentration and Prognostic Influence in Acute Ischemic Stroke
03:00 PM - 07:00 PM Abstract 080 - Association of Plasma Adiponectin with Extent of Brain Injury, Clinical Severity and Early Mortality in Patients with Ischemic Stroke
03:00 PM - 07:00 PM Abstract 081 - Association of Cardiovascular History and Elevated Troponin Levels in Acute Stroke Patients
03:00 PM - 07:00 PM Abstract 082 - Clinical Significance of Routine Transthoracic Echocardiography (TTE) in the Management of Cryptogenic Stroke
03:00 PM - 07:00 PM Abstract 083 - Segmental Left Ventricular Wall Motion Abnormalities and Ischemic Stroke
03:00 PM - 07:00 PM Abstract 084 - Echocardiography for the Inpatient Management of Cerebral Ischemia. Revisiting an Old Problem
03:00 PM - 07:00 PM Abstract 085 - Prevalence of Left Ventricular Hypertrophy in Patients with a Recent Cerebral Ischemic Event and Its Association with Aortic Arch Plaque as a Marker of Atherosclerosis
03:00 PM - 07:00 PM Abstract 086 - Echocardiography for Evaluating Ischemic Stroke Patients Varies across Stroke Centers: Implications for Comprehensive Stroke Center Guidelines
03:00 PM - 07:00 PM Abstract 087 - Seizures Are Common in the Acute Setting of Childhood Stroke - A Population-Based Study
03:00 PM - 07:00 PM Abstract 088 - Telemedicine Facillitates Early Treatment of Acute Ischemic Stroke in a Rural Hospital Network
03:00 PM - 07:00 PM Abstract 089 - Improvement in Midline Shift Is Not Associated with Improvement of Consciousness in Decompressive Hemicraniectomy for Middle Cerebral Artery Infarction
03:00 PM - 07:00 PM Abstract 090 - Experience with Strict Adherence to National Institute of Health Protocol and Keeping Door to Needle Time under 60 Minutes in a Community Hospital in Acute Thrombolysis with rt-PA in Stroke
03:00 PM - 07:00 PM Abstract 091 - Experience Using TPA for Acute Stroke in a Rural Setting: Retrospective Analysis
03:00 PM - 07:00 PM Abstract 092 - Thrombolysis in Stroke: Malpractice Issues Facing Neurologists - An 好色先生al Approach
03:00 PM - 07:00 PM Abstract 093 - Central Periodic Breathing during Sleep in Acute Ischemic Stroke
03:00 PM - 07:00 PM Abstract 094 - Leukoaraiosis and Collaterals in Acute Ischemic Stroke
03:00 PM - 07:00 PM Abstract 095 - Topography of Acute Brain Infarction in CNS Vasculitis
03:00 PM - 07:00 PM Abstract 096 - Blood Monocytes CD36 and HLA-DR Expressions Are Related to Carotid Plaques
03:00 PM - 07:00 PM Abstract 097 - Safety and Image Quality of High-Field Magnetic Resonance Angiography in Patients with Neurovascular Stents
03:00 PM - 07:00 PM Abstract 098 - Bradycardia and Hypotension in Carotid Artery Angioplasty and Stenting: Analysis of 96 Procedures
03:00 PM - 07:00 PM Abstract 099 - Early and Long-Term Outcomes with Drug Eluting Stents in High-Risk Patients with Symptomatic Intracranial Stenosis
03:00 PM - 07:00 PM Abstract 100 - High-Field Magnetic Angiography Assessment of Aortic Arch Type Prior to Endovascular Intervention
03:00 PM - 07:00 PM Abstract 101 - Endovascular Treatment of Acute Ischemic Stroke
03:00 PM - 07:00 PM Abstract 102 - Carotid Endarterectomy and Cognitive Functions: A Longitudinal Study
03:00 PM - 07:00 PM Abstract 103 - Endovascular Coil Embolization Treatment of Previously Clipped Cerebral Aneurysms
03:00 PM - 07:00 PM Abstract 104 - Extracranial Carotid Atherosclerosis in Patients with Intracranial Stenosis: Predictors and Influence on Prognosis
03:00 PM - 07:00 PM Abstract 105 - Stenting for Extra Cranial Carotid Stenosis: Time for a Trial Involving Asymptomatic Patients?
03:00 PM - 07:00 PM Abstract 106 - Vertebral Artery Origin Stent Placement with Distal Protection: Technical and Clinical Results
03:00 PM - 07:00 PM Abstract 107 - Clinical Application of Exercise Test in Patients with Periodic Paralysis
03:00 PM - 07:00 PM Abstract 108 - Statin-Induced Rhabdomyolysis with Myotonic Discharges
03:00 PM - 07:00 PM Abstract 109 - Anal Sphincter Motor Unit Potential (MUP) Differences between Sides, and between Rest and Voluntary Contraction in Normal Subjects
03:00 PM - 07:00 PM Abstract 110 - Predictors of EMG Utility in Lumbosacral Radiculopathy
03:00 PM - 07:00 PM Abstract 111 - A New Entrapment Syndrome
03:00 PM - 07:00 PM Abstract 112 - The Frequency of Median Neuropathy among Symptomatic and Asymptomatic Workers Exposed to Vibration
03:00 PM - 07:00 PM Abstract 113 - A Reasonable Flow Chart for Electrodiagnosis of Carpal Tunnel Syndrome
03:00 PM - 07:00 PM Abstract 114 - A Retrospective Analysis of Electrophysiologic Findings and Outcome in Bell's Palsy
03:00 PM - 07:00 PM Abstract 115 - Sural Sparing Axonal Neuropathy
03:00 PM - 07:00 PM Abstract 116 - Intra-Operative Nerve Conduction Study and Conversion Factor in the Sural Nerve
03:00 PM - 07:00 PM Abstract 117 - The Influence of Normal Aging on Functional Connectivity of Human Motor Network at Resting State
03:00 PM - 07:00 PM Abstract 118 - Cerebellar Activation by Repetitive Stimuli: As in the Colliculi, Visual Is Higher Than Auditory
03:00 PM - 07:00 PM Abstract 119 - MR Microscopy and In Vivo Clinical Neuropathology
03:00 PM - 07:00 PM Abstract 120 - Human Specific Organization of the Motor Cortex Determined by High-Field fMRI ICS Analysis
03:00 PM - 07:00 PM Abstract 121 - Real-Time EEG during Functional MRI
03:00 PM - 07:00 PM Abstract 122 - Glucose Metabolism in Continuous Visual Stimulation: Time-Dependent Changes in Visual Cortex
03:00 PM - 07:00 PM Abstract 123 - Incidence of Dysferlinopathy in Patients Initially Diagnosed with Polymyositis
03:00 PM - 07:00 PM Abstract 124 - Muscle Pathology in 31 Patients with Calpain3 Gene Mutations
03:00 PM - 07:00 PM Abstract 125 - Neuronal Nitric Oxide Synthase (nNOS) Activity and Ultrastructural Changes in Caveolin-3 Deficient Muscle Cause Mechanical Irritability
03:00 PM - 07:00 PM Abstract 126 - Alpha-Dystroglycan ([alpha]-DG) Hypoglycosylation in Limb Girdle Muscular Dystrophies (LGMD)
03:00 PM - 07:00 PM Abstract 127 - Treatment with Intravenous Immunoglobulin Improves Muscle Strength in a Patient with Dysferlin-Deficient Muscular Dystrophy
03:00 PM - 07:00 PM Abstract 128 - Structure Function Relationship of Dysferlin Inferred from Analysis of Mutational Databases and Computerized Structural Predictions
03:00 PM - 07:00 PM Abstract 129 - Life Expectancy and Quality of Life in Oculopharyngeal Muscular Dystrophy Patients with the (GCG)9 Expansion on PABPN1
03:00 PM - 07:00 PM Abstract 130 - Identification of a Desmin Gene Mutation in Scapuloperoneal Syndrome Type Kaeser
03:00 PM - 07:00 PM Abstract 131 - A CINRG Pilot Trial of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy
03:00 PM - 07:00 PM Abstract 132 - Adenovirus-Mediated Utrophin Gene Delivery as a Therapy for Duchenne Muscular Dystrophy
03:00 PM - 07:00 PM Abstract 133 - Haploinsufficiency of Utrophin Gene Worsens Diaphragm and Quadriceps Muscle Dystrophy in Mdx Mice
03:00 PM - 07:00 PM Abstract 134 - Absence of T-Cells and B-Cells Does Not Improve Functional Outcome in mdx Mice
03:00 PM - 07:00 PM Abstract 135 - Recombinant AAV and Corticosteroid Therapy in mdx Mice: In Consideration for Clinical Trials
03:00 PM - 07:00 PM Abstract 136 - Artificial Zinc Finger Proteins for the Transcriptional Regulation of Utrophin
03:00 PM - 07:00 PM Abstract 137 - The Course and Outcome of Pregnancy and Delivery in Women with Facioscapulohumeral Muscular Dystrophy
03:00 PM - 07:00 PM Abstract 138 - Pilot Trial of Diltiazem in Facioscapulohumeral Muscular Dystrophy
03:00 PM - 07:00 PM Abstract 140 - A Comparison of Adult Versus Juvenile Tic Clinical Characteristics
03:00 PM - 07:00 PM Abstract 141 - The Impact of Co-Morbidities on Quality of Life in Gilles de la Tourette Syndrome
03:00 PM - 07:00 PM Abstract 142 - A Double Blind Placebo Control Trial of Levetiracetam in Tourette Syndrome
03:00 PM - 07:00 PM Abstract 143 - Atomoxetine Treatment of ADHD in Children with Comorbid Tourette Syndrome
03:00 PM - 07:00 PM Abstract 144 - Bilateral GPi Deep Brain Stimulation for Tourette Syndrome
03:00 PM - 07:00 PM Abstract 145 - Visual Dysfunction in Independently Living Patients with Huntington's Disease
03:00 PM - 07:00 PM Abstract 146 - Error Related Negativity Is Increased in Huntington Disease
03:00 PM - 07:00 PM Abstract 147 - Dissociations in the Relationship between Apathy and Cognition in Huntington's Disease and Alzheimer's Disease
03:00 PM - 07:00 PM Abstract 148 - Effects of Coenzyme Q10 in PSP and CBD: A Randomized, Placebo-Controlled, Double-Blind, Crossover Pilot Study
03:00 PM - 07:00 PM Abstract 150 - Development and Validation of the Hereditary Spastic Paraplegia Rating Scale (HSPRS)
03:00 PM - 07:00 PM Abstract 151 - Clinical and Genetic Study of a Brazilian Family with Spastic Paraplegia (SPG6 Locus)
03:00 PM - 07:00 PM Abstract 152 - Complex Motor Stereotypies: Evidence for Autosomal Dominant Inheritance
03:00 PM - 07:00 PM Abstract 153 - Oxcarbazepine Use in Idiopathic Childhood Paroxysmal Kinesigenic Dyskinesia: Report of Effective Treatment in Four Unrelated Patients
03:00 PM - 07:00 PM Abstract 154 - Heterogeneity of MMPI-2 Abnormalities in Patients with Psychogenic Movement Disorders Suggests the Need for Diverse Therapeutic Approaches
03:00 PM - 07:00 PM Abstract 155 - Breath Holding: A Red Flag Suggesting a Psychogenic Movement Disorder
03:00 PM - 07:00 PM Abstract 156 - Prevalence of Pseudobulbar Affect in Movement Disorders and Its Mood Correlates: A Prospective Study of 754 Consecutive Patients
03:00 PM - 07:00 PM Abstract 157 - Functional Magnetic Resonance Imaging (fMRI) in Synkinesias Related to Alteration of the Dopamine System
03:00 PM - 07:00 PM Abstract 158 - Chronic Pallidal Deep Brain Stimulation in Neuro-Acanthocytosis (NA) Movement Disorders
03:00 PM - 07:00 PM Abstract 159 - Progressive Ataxia and Deafness Due to Superficial Siderosis: Associations and Therapeutic Implication
03:00 PM - 07:00 PM Abstract 160 - Mitoxantron Treatment Leads to a Persistent Selective Decrease of the B Cell Count in Patients with Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 161 - The Plasminogen Activator Inhibitor 1 - Plasminogen System and Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 162 - Lack of Reactivity against Liquid-Phase Myelin/Oligodendrocyte Glycoprotein in Multiple Sclerosis Sera
03:00 PM - 07:00 PM Abstract 163 - Glatiramer Acetate Induced Gene Expression Regulatory Networks in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 164 - Bri-CT Amyloid Peptide Levels Are Decreased in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients
03:00 PM - 07:00 PM Abstract 165 - Relapsing-Remitting Multiple Sclerosis and Oligoclonal Band Pattern during Disease-Modifying Drug Therapy
03:00 PM - 07:00 PM Abstract 166 - Defective Regulation of ATM in PBMC in a Subset of Patients with MS
03:00 PM - 07:00 PM Abstract 167 - Expression of CCL2, CXCL10 and Their Receptors CCR2 and CXCR3 by Primary Adult Human Astrocytes In Vitro: Effect of Pro-Inflammatory Cytokines
03:00 PM - 07:00 PM Abstract 168 - Fetuin-A Levels Are Elevated in Cerebrospinal Fluid of Patients with Secondary Progressive Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 169 - Identification of CSF Proteome Modifications in Multiple Sclerosis Using a Protein Chip Array Technology
03:00 PM - 07:00 PM Abstract 170 - Peripheral Blood Mononuclear Cells from Patients with MS Show Decreased Activation of STAT4 by Interferon-beta and Reduced Expression of Interferon Type 1 Receptor
03:00 PM - 07:00 PM Abstract 171 - Immunological Studies of Mitoxantrone in Primary Progressive MS
03:00 PM - 07:00 PM Abstract 173 - Antibodies Produced by Clonally Expanded Plasma Cells in the Cerebrospinal Fluid of MS Patients Display CNS Autoreactivity
03:00 PM - 07:00 PM Abstract 174 - Increased Expression of IL-10, TNF, and IL-23 but No Major Th1-Th2 Shift in Interferon-Treated MS
03:00 PM - 07:00 PM Abstract 175 - A 2-Year Longitudinal Gene Expression Profiling in PBMCs of MS Patients Receiving Interferon Beta 1b Therapy
03:00 PM - 07:00 PM Abstract 176 - Loss of Inhibitory Function of CD4+CD25+ Regulatory T Cells in Multiple Sclerosis Patients
03:00 PM - 07:00 PM Abstract 177 - Neuron and Axon Reactive Antibodies in the Cortex and Adjacent Normal Appearing White Matter in Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 178 - Association of T-Lymphocyte Infiltrate with Demyelinating Activity, Tissue Injury and Repair, and Immunopathological Patterns in Early Multiple Sclerosis (MS) Lesions
03:00 PM - 07:00 PM Abstract 179 - Spinal Cord Gray Matter Is a Predilection Site for Demyelination in Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 180 - Clavotrapezius Ischemic Change the Behavior Answer of the Orofacial Pain. Evidence of Trigemino-Cervical Convergence
03:00 PM - 07:00 PM Abstract 181 - Neonatal Immune Challenge Alters Nociception in Adulthood
03:00 PM - 07:00 PM Abstract 182 - Impaired Arterial Tone in Patients with Migraine with Aura during Headache-Free Periods
03:00 PM - 07:00 PM Abstract 183 - Intra-Pulmonary Artery as Compared to Peripheral Venous Dosing of Dihydroergotamin (DHE) in Telemetrised, Awake Dogs
03:00 PM - 07:00 PM Abstract 184 - Gastric Transit and Absorption of Reformulated and Conventional Sumatriptan Tablets in Migraineurs Both during and outside of a Migraine Attack: Evaluation by Gastric Scintigraphy
03:00 PM - 07:00 PM Abstract 185 - Psychophysical Markers of Windup in the Trigeminal System: Measurements Associated with Treatment of Medication Overuse Headaches (MOH)
03:00 PM - 07:00 PM Abstract 186 - Pregabalin Acts at Calcium Channel Alpha2-Delta ([alpha]2-[delta]) Type 1 Proteins To Prevent Stress-Induced Increases in Cerebellar cGMP
03:00 PM - 07:00 PM Abstract 187 - Effects of Comorbid Anxiety Symptoms on the Efficacy of Pregabalin for Treating Pain in a Central Neuropathic Pain Model
03:00 PM - 07:00 PM Abstract 188 - Antinociceptive Effect of Botulinum Toxin Type A in Experiemtal Diabetic Neuropathy
03:00 PM - 07:00 PM Abstract 189 - Botulinum Toxin, Type A (BoNT-A) for the Treatment of Cervicalgia and Cervicogenic Headache: Results of a Single Center, Randomized, Double-Blind, Active Placebo-Controlled Trial
03:00 PM - 07:00 PM Abstract 190 - Subcutaneous Botulinum Neurotoxin Type A Inhibits Streptozotocin (STZ)-Induced Chronic Pain in a Rat Model of Peripheral Diabetic Neuropathy
03:00 PM - 07:00 PM Abstract 191 - Gelstat Is Effective in Relieving Migraine Pain in a Double-Blind, Placebo-Controlled Study
03:00 PM - 07:00 PM Abstract 192 - Novel Aerosol Delivery of Ergotamine Tartrate Via Tempo[trade] in Humans
03:00 PM - 07:00 PM Abstract 193 - Resolution of SUNCT Attacks after Removal of an Acromegalic Pituitary Adenoma
03:00 PM - 07:00 PM Abstract 194 - Botulinum Toxin Type A Compared with Divalproex Sodium for the Prophylactic Treatment of Migraine: A Randomized, Evaluator-Masked Trial
05:30 PM - 07:00 PM Refreshments
Faculty Disclosures
Kapil D. Sethi, MD, FRCP (UK), FAAN Dr. Sethi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine.
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Todd D. Rozen, MD, FAAN No disclosure on file
Kathleen M. Shannon, MD, FAAN The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Gregory W. Albers, MD No disclosure on file
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Gil I. Wolfe, MD, FAAN Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Michael Glantz, MD, FAAN No disclosure on file
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
S. C. Johnston, MD, PhD, FAAN No disclosure on file
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Michael R. Sperling, MD, FAAN Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Jose Biller, MD, FACP, FAHA, FAAN Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Bradford B. Worrall, MD, MSc, FAAN The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Michael A. Williams, MD, FAAN Dr. Williams has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for the Hydrocephalus Association, a not-for-profit patient advocacay organization. The institution of Dr. Williams has received research support from NASA. The institution of Dr. Williams has received research support from Translational Research Insitute for Space Health (TRISH). The institution of Dr. Williams has received research support from NINDS.
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Joseph F. Drazkowski, MD, FAAN Dr. Drazkowski has nothing to disclose.
John W. Henson, MD, FAAN No disclosure on file
Oksana Suchowersky, MD, FAAN Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Victor W. Henderson, MD, FAAN Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities.
Jeffrey L. Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Kenneth M. Heilman, MD, FAAN Dr. Heilman has received publishing royalties from a publication relating to health care.
Herbert B. Newton, MD No disclosure on file
Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Joseph I. Sirven, MD, FAAN Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Neeraj Kumar, MD Dr. Kumar has nothing to disclose.
Jasper R. Daube, MD, FAAN No disclosure on file
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Christopher Goetz, MD, FAAN The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Frank G. Gilliam, MD, MPH No disclosure on file
Richard A. Bernstein, MD No disclosure on file
Marc Chamberlain, MD No disclosure on file
Josep O. Dalmau, MD, PhD, FAAN Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Helena C. Chui, MD The institution of Dr. Chui has received research support from National Institute on Aging .
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Jody Corey-Bloom, MD, PhD, FAAN Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.
Thomas G. Brott, MD, FAAN Dr. Brott has nothing to disclose.
Beth A. Malow, MD, MS, FAAN Dr. Malow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Pharmaceuticals. The institution of Dr. Malow has received research support from National Institutes of Health. The institution of Dr. Malow has received research support from Department of Defense. The institution of Dr. Malow has received research support from PCORI.
Katherine H. Noe, MD, PhD, FAAN Dr. Noe has a non-compensated relationship as a committe member, Epilepsy MOC article review pilot with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Michael N. Diringer, MD No disclosure on file
Eelco F. Wijdicks, MD, FAAN Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Joseph C. Masdeu, MD, PhD, FAAN Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Michael J. Schneck, MD, FAAN An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Benn E. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSP Behring.
Mark A. Ross, MD, FAAN No disclosure on file
William Jagust, MD No disclosure on file
Michael Sinnreich, MD, PhD Prof. Sinnreich has nothing to disclose.
Joseph P. Broderick, MD, FAAN The institution of Dr. Broderick has received research support from Novo Nordisk. Dr. Broderick has received publishing royalties from a publication relating to health care.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Henry L. Paulson, MD, PhD, FAAN Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Emma Ciafaloni, MD, FAAN Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Matthew Rizzo, MD, FAAN The institution of Dr. Rizzo has received research support from NIH.
Harvey S. Singer, MD, FAAN No disclosure on file
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Robert A. Gross, MD, PhD, FAAN Dr. Gross has received publishing royalties from a publication relating to health care.
Lynne P. Taylor, MD, FAAN Dr. Taylor has received publishing royalties from a publication relating to health care.
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Camilo E. Fadul, MD, FAAN No disclosure on file
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Camilo R. Gomez, MD, FAAN Dr. Gomez has nothing to disclose.
Osama O. Zaidat, MD, FAAN Dr. Zaidat has nothing to disclose.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Sandra E. Black, MD, FAAN Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Claudia Kawas, MD The institution of Dr. Kawas has received research support from NIH.
Henry J. Kaminski, MD, FAAN Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Kristine Yaffe, MD Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Gloria Galloway, MD, FAAN No disclosure on file
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Robert L. Rodnitzky, MD, FAAN No disclosure on file
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Tracy T. Batchelor, MD, MPH Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Bradley V. Vaughn, MD, FAAN Dr. Vaughn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical 好色先生 Resources. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has a non-compensated relationship as a speaker/course director with AAN that is relevant to AAN interests or activities.
Anne M. Connolly, MD, FAAN Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. The institution of Dr. Connolly has received research support from Muscular Dystrophy Association. The institution of Dr. Connolly has received research support from NIH.
Maciej M. Mrugala, MD, PhD, MPH, FAAN Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
J. Americo M. Fernandes, Jr., MD, FAAN Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
Alireza Yarahmadi, MD No disclosure on file
Manjari Tripathi, MD Dr. Tripathi has nothing to disclose.
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
Vivien H. Lee, MD, FAAN Dr. Lee has nothing to disclose.
Latisha Sharma, MD Dr. Sharma has nothing to disclose.
No disclosure on file
Tina T. Shih, MD No disclosure on file
Robert Goodman No disclosure on file
Diana Apetauerova, MD Dr. Apetauerova has nothing to disclose.
Sharon Lamont No disclosure on file
Stephanie Scala No disclosure on file
Lauren E. Abrey, MD No disclosure on file
Tsutomu Nakada, MD, PhD No disclosure on file
Ingrid L. Kwee, MD Dr. Kwee has nothing to disclose.
Michael I. Weintraub, MD, FACP, PC, FAAN Dr. Weintraub has nothing to disclose.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Corrado Angelini, MD, FAAN Dr. Angelini has nothing to disclose.
Nina Paleologos, MD No disclosure on file
Gregory Christoforidis No disclosure on file
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Andrei G. Vlassenko, MD, PhD No disclosure on file
Mark A. Mintun, MD Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.
Daniel Becker, MD Dr. Becker has nothing to disclose.
Adrian A. Jarquin-Valdivia, MD, none No disclosure on file
Shoji Hemmi, MD No disclosure on file
Yuki Hatanaka, MD No disclosure on file
Shin J. Oh, MD, FAAN No disclosure on file
Ming-hong Chang, MD Dr. Chang has nothing to disclose.
Anat Achiron, MD, PhD, FAAN Dr. Achiron has nothing to disclose.
Esther Cubo Delgado, MD, PhD, FAAN Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Teresa Chmura, BS No disclosure on file
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Ergun Y. Uc, MD An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Jane S. Paulsen, PhD Dr. Paulsen has received personal compensation in the range of $0-$499 for serving as a Consultant for CHDI. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for HDSA. The institution of Dr. Paulsen has received research support from NIH/NIA. The institution of Dr. Paulsen has received research support from NIH/NINDS.
Jeffrey Dawson Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Congress of Neurological Surgeons. The institution of Jeffrey Dawson has received research support from Department of Veterans Affairs. The institution of Jeffrey Dawson has received research support from NIH.
William J. Weiner, MD No disclosure on file
Lisa M. Shulman, MD, FAAN The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Karen Anderson No disclosure on file
Iftekhar Ahmed, MD, PC, FAAN Dr. Ahmed has nothing to disclose.
Julian Benito-Leon No disclosure on file
Alrabi Tawil, MD, FAAN Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for meRicule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care.
Alexis Smirnow No disclosure on file
Norman Putzki, MD No disclosure on file
Volker Limmroth, MD, PhD No disclosure on file
Manoj Kumar No disclosure on file
Didier Lefranc, MD No disclosure on file
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
David B. Rosenfield, MD, FAAN No disclosure on file
David Hess, MD No disclosure on file
James E. Galvin, MD, MPH Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Catherine M. Roe, PhD No disclosure on file
Chengjie Xiong, PhD Chengjie Xiong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DIADEM.
Rosana H. Scola, MD Dr. Scola has nothing to disclose.
Lineu C. Werneck, MD No disclosure on file
Helio Afonso G. Teive, MD, PhD, FAAN Dr. Teive has nothing to disclose.
Yank Kwang Ik, PhD No disclosure on file
Yeong-Bae Lee, PhD No disclosure on file
Mark J. Stillman, MD, FAAN No disclosure on file
Maria Corrada, PhD The institution of Dr. Corrada has received research support from NIH.
Kristin Kahle-Wrobleski No disclosure on file
Lorraine L. Edwards, MD, FAAN No disclosure on file
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Allyson Zazulia An immediate family member of Dr. Zazulia has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care Society.
Nils H. Mueller, MD No disclosure on file
Boby V. Maramattom, MD Dr. Maramattom has nothing to disclose.
R. A. Wright, MD, FRACP, MB, ChB No disclosure on file
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Rivka Inzelberg, MD No disclosure on file
Claudio Mariani, MD No disclosure on file
Pierluigi Bertora No disclosure on file
Seong B. Koh, MD No disclosure on file
Jeyaraj D. Pandian, MD, DM Dr. Pandian has nothing to disclose.
Sanjeev V. Thomas, MD, FAAN Dr. Thomas has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley India. The institution of Dr. Thomas has received research support from Government of India.
Kirti Patil No disclosure on file
Dong Jin Shin, MD Dr. Shin has nothing to disclose.
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Gregory Crucian No disclosure on file
Antonio Strafella, MD No disclosure on file
Francois Tison, MD, PhD No disclosure on file
Kirk Roberts, MD, FAAN Dr. Roberts has nothing to disclose.
Pedro A. Kowacs, MD, FAAN Dr. Kowacs has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Elcio J. Piovesan, MD Dr. Piovesan has nothing to disclose.
Hanns Lochmuller, MD, FAAN Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CCRM. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Canada Inc. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satellos. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for KYE Pharma. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lochmuller has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satellos. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precision. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Ola A. Selnes, PhD No disclosure on file
Richard L. Skolasky, BA No disclosure on file
Marinella Clerico, MD Dr. Clerico has nothing to disclose.
Andrea Falini No disclosure on file
George W. Padberg, MD, PhD, FAAN No disclosure on file
Marielle Wohlgemuth, MD No disclosure on file
Maria J. Molnar, MD, PhD Dr. Molnar has nothing to disclose.
Renald Gilbert, PhD No disclosure on file
Basil J. Petrof, MD No disclosure on file
Josephine Nalbantoglu No disclosure on file
George Karpati, MD No disclosure on file
Anna Feldman No disclosure on file
Michael Gurevich No disclosure on file
Piu Chan, MD, PhD No disclosure on file
Tao Wu No disclosure on file
Geun-Yong Um, MD No disclosure on file
Kevin R. Joseph, DO No disclosure on file
William Shih, MD No disclosure on file
John Ney, MD, MPH, FAAN Dr. Ney has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Ney has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
David FitzGerald, MD No disclosure on file
Yahia M. Lodi, MD, FAAN Dr. Lodi has nothing to disclose.
Arshad Majid, MD Dr. Majid has received publishing royalties from a publication relating to health care.
Mounzer Kassab, MD No disclosure on file
Mohammad Sajed, MD Dr. Sajed has nothing to disclose.
John M. Whapham, MD, FAAN No disclosure on file
Jan Mares, MD Dr. Mares has nothing to disclose.
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Petr Hlustik, MD, PhD The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Karel Urbanek No disclosure on file
Hana Vranova, MD No disclosure on file
Michael A. Farrell, MB No disclosure on file
Lars Bo, MD, PhD No disclosure on file
Karadan Ummer, MD, FAAN No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
David S. Liebeskind, MD, FAAN Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Sidney Starkman, MD, FAAN No disclosure on file
Nerses Sanossian, MD, FAAN Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Doojin Kim, MD No disclosure on file
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Marc Weisskopf, PhD Prof. Weisskopf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaiser Permanente Research Biobank. The institution of Prof. Weisskopf has received research support from ALS Network. The institution of Prof. Weisskopf has received research support from NIH. The institution of Prof. Weisskopf has received research support from Paralyzed Veterans of America. The institution of Prof. Weisskopf has received research support from CDC/ATSDR. The institution of Prof. Weisskopf has received research support from JPB Foundation.
Lan Zhou, MD, PhD The institution of Dr. Zhou has received research support from NIH.
John D. Porter, PhD No disclosure on file
Saadat Kamran, MD No disclosure on file
Dirk T. Deleu, MD, PhD, FRCP, FAAN Dr. Deleu has nothing to disclose.
Ahmed I. Hamad, MD No disclosure on file
Dominique Guehl No disclosure on file
Igor Sibon No disclosure on file
Pierre Burbaud, MD, PhD No disclosure on file
James T. Becker, PhD No disclosure on file
Stephen D. Samples, MD No disclosure on file
Arnaud Lacour No disclosure on file
Julaine M. Florence Ms. Florence has nothing to disclose.
Diana M. Escolar, MD, FAAN No disclosure on file
Robert T. Leshner, MD, FAAN No disclosure on file
Gunnar Buyse, MD, PhD No disclosure on file
Nathalie M. Goemans, MD Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Goemans has received publishing royalties from a publication relating to health care.
Erik K. Henricson, MPH No disclosure on file
Nilufer Taner, MD, PhD, FAAN The institution of Dr. Taner has received research support from NIH.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Mariet Allen, PhD The institution of Dr. Allen has received research support from NIH. The institution of Dr. Allen has received research support from Florida Department of Health. Dr. Allen has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Steven G. Younkin, MD, PhD No disclosure on file
M.Ascension Zea Sevilla No disclosure on file
Pilar De Juan Hernandez No disclosure on file
Netta Levin, MD, PhD Dr. Levin has nothing to disclose.
Tali Siegal, MD No disclosure on file
Dirk Fischer The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann La Roche AG. The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann La Roche AG.
Matthias Vorgerd Matthias Vorgerd has nothing to disclose.
Maggie C. Walter, MD No disclosure on file
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
David P. Salmon, PhD Dr. Salmon has nothing to disclose.
John M. Ravits, MD, FAAN Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze, Inc. Dr. Ravits has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Transposon, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Libra, Inc. The institution of Dr. Ravits has received research support from NIH R21 Research Grant. The institution of Dr. Ravits has received research support from NIH R01 Research Grant. The institution of Dr. Ravits has received research support from FightMND Foundation Research Grant. The institution of Dr. Ravits has received research support from DOD Research Grant. Dr. Ravits has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH Office of Scientific Review.
Sharon P. Nations, MD, FAAN No disclosure on file
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Nazli A. Janjua, MD, MBBS Dr. Janjua has nothing to disclose.
Joseph F. Quinn, MD, FAAN Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Jeffrey A. Kaye, MD, FAAN Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Joon-Shik Moon, MD Dr. Moon has nothing to disclose.
Adilia M. Hormigo, MD, PhD Dr. Hormigo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TargTex.
Lisa M. DeAngelis, MD, FAAN Dr. DeAngelis has received publishing royalties from a publication relating to health care.
Eric Holland No disclosure on file
Kwang-Dong Choi, MD No disclosure on file
Eun-Joo Kim, MD No disclosure on file
Duk L. Na, MD No disclosure on file
Elaine C. Wirrell, MD, FAAN Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Preeya Grewal, MD No disclosure on file
Stephen B. Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Nabih Ramadan, MD, FAAN Dr. Ramadan has nothing to disclose.
Harry Vinters No disclosure on file
Laurence J. Kinsella, MD, FAAN Dr. Kinsella has received publishing royalties from a publication relating to health care.
Cris S. Constantinescu, MD, PhD Dr. Constantinescu has received publishing royalties from a publication relating to health care.
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Aaron McMurtray, MD, FAAN The institution of an immediate family member of Dr. McMurtray has received research support from US Government . An immediate family member of Dr. McMurtray has received intellectual property interests from a discovery or technology relating to health care. Dr. McMurtray has received personal compensation in the range of $100,000-$499,999 for serving as a Panel member with Legal Firm.
Eliot A. Licht, MD No disclosure on file
Ronald E. Saul, MD, FAAN No disclosure on file
Lysa Boissé Lomax, MD Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB, Eisai, Sunovion. Dr. Boissé Lomax has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Correctional Service Canada. The institution of Dr. Boissé Lomax has received research support from UCB.
Sture Eriksson, MD No disclosure on file
Lena Kilander No disclosure on file
Bengt Winblad No disclosure on file
Anders Haglund No disclosure on file
John G. Oas, MD No disclosure on file
Joachim F. Wernicke, MD, PhD No disclosure on file
Dustin Ruff Dustin Ruff has received personal compensation for serving as an employee of Eli Lilly and Company. Dustin Ruff has stock in Eli Lilly and Company.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
David W. Dunn, MD Dr. Dunn has nothing to disclose.
Thomas Spencer, MD No disclosure on file
Peter D. Feldman, PhD No disclosure on file
Steven Shook, MD Dr. Shook has nothing to disclose.
Christopher J. Kenney, MD, FAAN Dr. Kenney has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Kenney has or had stock in Xenon Pharmaceuticals.
Arthur H. Weiss, MD, FAAN No disclosure on file
Jun Goto, MD, PhD No disclosure on file
Fred H. Hochberg, MD No disclosure on file
Bruce R. Reed, PhD No disclosure on file
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Michael Oshinsky, PhD No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH.
Ging-Yuek R. Hsiung, MD, FAAN Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen.
Kevin Peters No disclosure on file
Claudia Jacova No disclosure on file
Howard Feldman, MD, FAAN The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Antal Szabo, MD No disclosure on file
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Shafeeq Ladha, MD Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi. Dr. Ladha has received publishing royalties from a publication relating to health care.
Bahman Jabbari, MD, FAAN Dr. Jabbari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jabbari has received publishing royalties from a publication relating to health care.
Mauro Magoni, MD No disclosure on file
Angelo Costa, MD No disclosure on file
Shashidhar Kori, MD Dr. Kori has received personal compensation for serving as an employee of Novilla Pharma. Dr. Kori has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Satsuma Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Tonix Pharma. Dr. Kori has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Exalys Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for NewBio Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for Afsci Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trigemina Inc. Dr. Kori has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Novilla Pharma. Dr. Kori has received stock or an ownership interest from Novilla Pharma. Dr. Kori has received stock or an ownership interest from NewBio Pharma. Dr. Kori has received stock or an ownership interest from Tonix Pharma. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Reviewer of grant applications with Department of Defense.
Susan C. Byrd, RPh No disclosure on file
Vanda Lennon, MD, PhD The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Susan A. McDonald, MA No disclosure on file
Christopher Shilling, MS No disclosure on file
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Tarakad S. Ramachandran, MD, FAAN No disclosure on file
Scott J. Peak, MD No disclosure on file
Nidhi K. Watson, MD No disclosure on file
Mohamad A. Mikati, MD No disclosure on file
Hanna-Maija Kuusisto, MD No disclosure on file
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Irina Elovaara, MD, PhD No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Andrew B. Lassman, MD, FAAN No disclosure on file
Ulrich Bogdahn, MD No disclosure on file
Marc P. Difazio, MD No disclosure on file
Antonio V. Delgado-Escueta, MD Dr. Delgado-Escueta has nothing to disclose.
Chai Tian, PhD No disclosure on file
Kyosti Sotaniemi No disclosure on file
Juha Korpelainen No disclosure on file
Anne M. Makikallio, PhD No disclosure on file
Vilho V. Myllyla, MD No disclosure on file
Siddarth Kharkar, MD No disclosure on file
Wallace W. Tourtellotte, MD, PhD, FAAN No disclosure on file
Stanley van den Noort, MD No disclosure on file
Yufen Qin, MD No disclosure on file
Yiping Zhang No disclosure on file
Rengrong Da No disclosure on file
Mauricio Medina, MD No disclosure on file
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
Susan D. Rountree, MD No disclosure on file
Valory Pavlik, PhD The institution of Dr. Pavlik has received research support from Alzheimer's Association.
Robert C. Green, MD, MPH No disclosure on file
Paul J. Massman, PhD No disclosure on file
Beate Winner, MD No disclosure on file
Charles P. Taylor No disclosure on file
B. Douglas Campbell, MD No disclosure on file
Claudio L. Bassetti, MD No disclosure on file
Brian McNamara, MD Dr. McNamara has nothing to disclose.
Jagarlapudi M. Murthy, MD, FAAN Dr. Murthy has nothing to disclose.
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Daniel H. Lachance, MD, FAAN Dr. Lachance has nothing to disclose.
Jeffrey A. Switzer, DO, FAAN Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving as a Expert Speaker on a panel with Genentech. Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with SAA Alumni Association.
Fenwick T. Nichols III, MD, FAAN Dr. Nichols has nothing to disclose.
Alex Hlubocky, MD No disclosure on file
Yazmin Odia, MD, MS, MBA, FAAN Dr. Odia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimeric, part of Jazz Pharmaceuticals.
Abelardo Q. Araujo, MD, PhD, MSc No disclosure on file
Claudia Cristina F. Vasconcelos, PhD No disclosure on file
Cristiane R. Afonso, MD No disclosure on file
Thomas McRae No disclosure on file
Sharon Richardson, PhD No disclosure on file
Honglan Li, PhD Dr. Li has received personal compensation for serving as an employee of Novo Nordisk Inc. Dr. Li has stock in Novo Nordisk Inc.
Luis Bataller, MD No disclosure on file
Margitta Seeck, MD, PhD No disclosure on file
John Papatriantafyllou, MD Dr. Papatriantafyllou has nothing to disclose.
Panagiotis Zikos, MD No disclosure on file
Lykourgos Kartsaklis No disclosure on file
Michael Vikelis, MD No disclosure on file
Steven W. Anderson, PhD Dr. Anderson has nothing to disclose.
Heidi S. Smith, DO No disclosure on file
Pedro Gonzalez-Alegre, MD Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuExcell. The institution of Dr. Gonzalez-Alegre has received research support from NIH/NINDS. Dr. Gonzalez-Alegre has received intellectual property interests from a discovery or technology relating to health care.
William R. Shapiro, MD No disclosure on file
Edwin Yau No disclosure on file
Seemant Chaturvedi, MD, FAHA, FAAN Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Marc I. Chimowitz, MD An immediate family member of Dr. Chimowitz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gore. Dr. Chimowitz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo Inc. The institution of Dr. Chimowitz has received research support from NIH.
John Langfitt, PhD No disclosure on file
Olga Prilipko No disclosure on file
Wojciech Kozubski, MD, PhD No disclosure on file
Slawomir Michalak, PhD No disclosure on file
Simone Spuler, MD No disclosure on file
Andrzej Szczudlik, MD No disclosure on file
Bruno Giometto, MD Dr. Giometto has nothing to disclose.
Roberta Vitaliani, MD No disclosure on file
Orna O'Toole, MB, BCh, BAO MD Dr. O'Toole has nothing to disclose.
Lindsey E. Kirsch Darrow No disclosure on file
Steve DeRoos, MD Dr. DeRoos has nothing to disclose.
Kipp L. Chillag, DO Dr. Chillag has nothing to disclose.
John M. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Roberto G. Gonzalez, MD, PhD No disclosure on file
John D. Fisk, PhD The institution of Dr. Fisk has received research support from Canadian Institutes of Health Research. The institution of Dr. Fisk has received research support from Multiple Sclerosis Society of Canada. Dr. Fisk has received publishing royalties from a publication relating to health care.
Hisatomo Kowa, MD, PhD No disclosure on file
Jaya Trivedi, MD, FAAN The institution of Dr. Trivedi has received research support from Avidity.
Tomas Olsson, MD, PhD Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Olsson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Prof. Olsson has received research support from Biogen. The institution of Prof. Olsson has received research support from Novartis. The institution of Prof. Olsson has received research support from Sanofi. The institution of Prof. Olsson has received research support from Merck.
Finn Sellebjerg, MD Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Scott L. Silliman, MD Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Michael R. Frankel, MD The institution of Dr. Frankel has received research support from Nico Corporation, Inc.
Cynthia McRae, PhD No disclosure on file
Ana-Claire L. Meyer, MD, FAAN Dr. Meyer has received personal compensation for serving as an employee of Denali Therapeutics.
Joan T. Moroney, MD, MRCPI No disclosure on file
Sinead M. Murphy, MD Dr. Murphy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. Murphy has received research support from Genomics Medicine Ireland. The institution of Dr. Murphy has received research support from Novartis.
Jaspreet Bhangu, MD No disclosure on file
Francesca Brett No disclosure on file
Bryan A. Bernard, PhD Dr. Bernard has nothing to disclose.
Dan M. Mungas, PhD Dr. Mungas has nothing to disclose.
Andreas Steinbrecher, MD No disclosure on file
Jin J. Luo, MD, PhD, FAAN Dr. Luo has nothing to disclose.
Bassel W. Abou-Khalil, MD, FAAN The institution of Dr. Abou-Khalil has received research support from Cerevel. The institution of Dr. Abou-Khalil has received research support from Xenon. The institution of Dr. Abou-Khalil has received research support from Otsuka. The institution of Dr. Abou-Khalil has received research support from UCB. The institution of Dr. Abou-Khalil has received research support from SK LIfe Science. The institution of Dr. Abou-Khalil has received research support from Neuroelectrics.
Tania F. Tayah, MD, FAAN Dr. Tayah has nothing to disclose.
Thomas H. Klopstock, MD Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GenSight Biologics. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GenSight Biologics.
Mustafa S. Siddiqui, MD, FAAN Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Robert H. Goertsches, PhD No disclosure on file
Hans A. Puttgen, MD No disclosure on file
Matthew A. Koenig, MD No disclosure on file
Robert Stevens No disclosure on file
Basil Sharrack, MD, PhD, FAAN Dr. Sharrack has nothing to disclose.
Omer Suliman No disclosure on file
Constance Smith-Hicks, MD, PhD The institution of Dr. Smith-Hicks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PaxMedica.
Laura M. Lynam, MD No disclosure on file
Deepak Madhavan, MD No disclosure on file
Haitham Hussein, MD, FAAN Dr. Hussein has nothing to disclose.
Nancy R. Foldvary-Schaefer, DO, FAAN Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Jocelyn F. Bautista, MD No disclosure on file
Muhammad Al-Lozi, MD Dr. Al-Lozi has nothing to disclose.
William G. Ellis, MD No disclosure on file
Massimiliano M. Siccoli, MD No disclosure on file
Subramaniam Sriram, MD Dr. Sriram has nothing to disclose.
Nunzio Pomara, PhD No disclosure on file
E Malca Resnick, PhD No disclosure on file
Brian R. Ott, MD No disclosure on file
Marta Banach, MD Dr. Banach has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz Pharmaceuticals GmbH. Dr. Banach has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz Pharmaceuticals GmbH. Dr. Banach has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Merz Pharmaceuticals GmbH.
Mohammad A. Mahmood, MD, MBBS Dr. Mahmood has stock in pfizer.
Yousef Mohammad, MD No disclosure on file
Krassen Nedeltchev No disclosure on file
Heinrich P. Mattle, MD No disclosure on file
Yaakov Stern, PhD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Andrew W. Diamanduros, MS, BS No disclosure on file
Violaine K. Harris, PhD No disclosure on file
Kenton Zavitz No disclosure on file
Suzanne Hendrix, PhD Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Andrew G. Herzog, MD, MSc, FAAN Dr. Herzog has nothing to disclose.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Donald L. Schomer, MD, FAAN No disclosure on file
Daniel Christensen No disclosure on file
Joyce D. Liporace, MD No disclosure on file
Bill Nikolov No disclosure on file
Kristen Fowler No disclosure on file
Elinor Ben-Menachem, MD, FAAN Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic.
Melanee Newman No disclosure on file
Blanca R. Vazquez, MD Dr. Vazquez has nothing to disclose.
Nabila Dahodwala, MD, FAAN Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Mark W. Jacobson, PhD No disclosure on file
Bong-Ho Lee, MD No disclosure on file
Holly B. Posner, MD No disclosure on file
John R. Gates, MD No disclosure on file
Wenbo Zhang, MD, PhD No disclosure on file
Deanna Dickens, MD No disclosure on file
Frank J. Ritter, MD No disclosure on file
Gail L. Risse, PhD No disclosure on file
Rachel J. Schindler, MD No disclosure on file
Steven Ferris No disclosure on file
Mahmood S. Eisa, MD, FAAN No disclosure on file
Todd Constable Todd Constable has nothing to disclose.
Rizma J. Bajwa, MD No disclosure on file
Zdravko Lackovic, MD, PhD No disclosure on file
A. D. Rothner, MD No disclosure on file
Linda M. Selwa, MD, FAAN Dr. Selwa has nothing to disclose.
Ronald D. Chervin, MD, MS No disclosure on file
Prakash Kotagal, MD, MBBS, FAAN No disclosure on file
Sheerin Thussu No disclosure on file
Glen H. Stevens, DO, PhD, FAAN The institution of Dr. Stevens has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. The institution of Dr. Stevens has received research support from National Cancer Institute.
Gene H. Barnett, MD Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Monteris Medical.
Christiana E. Hall, MD No disclosure on file
Robert J. Adams, MD No disclosure on file
Lisa R. Rogers, DO, FAAN Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Mark Rosenblum No disclosure on file
Jorge A. Gutierrez, MD No disclosure on file
Andreas F. Hottinger, MD The institution of Dr. Hottinger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novocure. The institution of Dr. Hottinger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. The institution of Dr. Hottinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure.
Jacob S. Elkins, MD No disclosure on file
Stephen Sidney, MD, MPH Dr. Sidney has nothing to disclose.
Rachel Whitmer, PhD Dr. Whitmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech . Dr. Whitmer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's and Dementia:Journal of the Alzheimer's Association . The institution of Dr. Whitmer has received research support from National. Institute of Health .
Bakri Elsheikh, MD, FAAN Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
Neil Cherian, MD Dr. Cherian has nothing to disclose.
Maryann Mays, MD, FAAN Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
Ahmad A. Beydoun, MD No disclosure on file
Nicola R. Donelan, PhD No disclosure on file
K. Roger Aoki, PhD No disclosure on file
Joseph Francis, PhD No disclosure on file
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Steven Fleming No disclosure on file
Arbi G. Ohanian, MD No disclosure on file
Brian H. Buck, MD No disclosure on file
Fernando Vinuela No disclosure on file
Mana Higashihara, MD No disclosure on file
Lumine Matsumoto, MD, PhD No disclosure on file
Sangwon Seo, MD No disclosure on file
William J. Litchy, MD, FAAN Dr. Litchy has nothing to disclose.
Nima Mowzoon, MD No disclosure on file
Norman Relkin, MD, PhD No disclosure on file
Wendy M. King, PT Ms. King has nothing to disclose.
Eric T. Wong, MD, FAAN Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Cathra Halabi, MD The institution of Dr. Halabi has received research support from UC Noyce Initiative. The institution of Dr. Halabi has received research support from Weill Institute for Neurosciences Neurohub. The institution of Dr. Halabi has received research support from NIH/NIDCD. The institution of Dr. Halabi has received research support from NIH/StrokeNet. Dr. Halabi has a non-compensated relationship as a Working Group Member with National Academies of Sciences, Engineering, and Medicine Action Collaborative on TBI Care that is relevant to AAN interests or activities. Dr. Halabi has a non-compensated relationship as a Working Group Member with NIH/StrokeNet Recovery and Rehabilitation Working Group that is relevant to AAN interests or activities.
Michael F. Waters, MD, PhD, FAAN Dr. Waters has nothing to disclose.
Norbert Goebels, MD Dr. Goebels has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Goebels has received research support from Sanofi-Genzyme.
Daniel C. Potts, MD, FAAN Dr. Potts has received publishing royalties from a publication relating to health care. Dr. Potts has a non-compensated relationship as a President with Cognitive Dynamics Foundation (non-profit) that is relevant to AAN interests or activities.
James D. Geyer, MD No disclosure on file
Morgan S. Campbell III, MD No disclosure on file
Susana M. Bowling, MD, FAAN Dr. Bowling has nothing to disclose.
Dawn O. Kleindorfer, MD, FAAN Dr. Kleindorfer has nothing to disclose.
Pooja Khatri, MD, FAAN The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Kathleen Alwell No disclosure on file
Lawrence D. Recht, MD, FAAN No disclosure on file
Robert Licho No disclosure on file
Rebecca Fisher, MD No disclosure on file
Stephen F. Sands, PhD No disclosure on file
Clara M. Pelfrey, PhD No disclosure on file
James R. Couch, Jr., MD, PhD, FAAN No disclosure on file
Joseph S. Jeret, MD, FAAN No disclosure on file
Til Menge, MD, FAAN No disclosure on file
Claude P. Genain, MD No disclosure on file
H.-Christian C. von Büdingen, MD, FAAN Dr. von Büdingen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. von Büdingen has stock in F. Hoffmann-La Roche Ltd.
Catherine Carey, PhD No disclosure on file
Sana Syed, DO No disclosure on file
Ammar Al Kawi, MD, FAAN Dr. Al Kawi has nothing to disclose.
Mohamed S. Ibrahim, MD No disclosure on file
Guerry M. Peavy, PhD Dr. Peavy has stock in MRK. Dr. Peavy has stock in ABT. Dr. Peavy has stock in JNJ. Dr. Peavy has stock in ABBV. The institution of an immediate family member of Dr. Peavy has received research support from NIH. The institution of Dr. Peavy has received research support from NIH.
Joanne M. Hamilton The institution of an immediate family member of Ms. Hamilton has received research support from Department of Veterans Affairs.
Kevin M. Barrett, MD, FAAN Dr. Barrett has nothing to disclose.
Roi A. Wallis, MD No disclosure on file
A.James Fessler III, MD, FAAN No disclosure on file
Sergiu C. Blumen, MD No disclosure on file
Ralph Carasso, MD, MSc No disclosure on file
Puiu Nisipeanu, MD, PhD No disclosure on file
Surasak Phuphanich, MD, FAAN No disclosure on file
Federico Silva, MD No disclosure on file
Sandra E. Silva, MD No disclosure on file
Gustavo Pradilla-Ardila, MD No disclosure on file
Douglas Galasko, MD Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics.
Paul Golumbek, MD, PhD No disclosure on file
John George F. Boughey, MD No disclosure on file
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Thomas J. Chippendale, MD No disclosure on file
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Oren Levy, MD Dr. Levy has received personal compensation for serving as an employee of Regeneron Pharmaceuticals . Dr. Levy has stock in Regeneron Pharmaceuticals .
Derek J. Chong, MD No disclosure on file
Viktor Szeder, MD, PhD Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Szeder has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Carroll, Kelly, Trotter, Franzen, McBride & Peabody LLP. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peabody and Buccini LLP.
Fiona E. Costello, MD Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Matthew Harinstein No disclosure on file
Peter J. Whitehouse, MD, PhD No disclosure on file
Joohi Jimenez Shahed, MD, FAAN Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with 好色先生. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
James Poysky, PhD No disclosure on file
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Franklin C. Wong, MD, PhD, JD, FAAN No disclosure on file
Morris D. Groves, Jr., MD No disclosure on file
Charles A. Conrad, MD No disclosure on file
Sigmund H. Hsu, MD No disclosure on file
Stella Lee No disclosure on file
Salvador Cruz-Flores, MD, FAAN The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Joyce H. Ma No disclosure on file
Madeline A. Chadehumbe, MD, FAAN Dr. Chadehumbe has nothing to disclose.
Deborah H. Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Sanjib Sinha, MD No disclosure on file
Christopher Streib, MD Dr. Streib has nothing to disclose.
Ty Shang, MD No disclosure on file
Rakesh Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Diego Torres-Russotto, MD, FAAN Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Tiffany L. Fisher, MD, PhD Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis, Inc.
Iris E. Martinez-Juarez, MD No disclosure on file
Chiara Pisciotta No disclosure on file
Dagmar Timmann-Braun No disclosure on file
Sarah Song, MD, MPH, FAAN Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN.
Eric N. Miller, PhD No disclosure on file
Mathias Maeurer, MD No disclosure on file
Benjamin Pagano No disclosure on file
Cynthia R. Murphy, MD No disclosure on file
Alexander A. Tarnutzer, MD No disclosure on file
Virginia Laura Parisi, MD No disclosure on file
James N. Brenton, MD, FAAN Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Ann B. Ragin, PhD No disclosure on file
Jose M. Serratosa, MD, PhD No disclosure on file
Mohan L. Noone, MD No disclosure on file
Sandra Vanotti, MD No disclosure on file
Muhammed Said Berilgen No disclosure on file
Paul Solomon, PhD No disclosure on file
Alison L. Walsh, MD Dr. Walsh has nothing to disclose.
Suola Wang No disclosure on file
Christina Sundal, MD Dr. Sundal has nothing to disclose.
Pavel Stourac, MD Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol- Myers Squibb. Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis .
Edo Bottacchi No disclosure on file
Mitra Assadi Khansare, MD, FAAN No disclosure on file
Umberto Manera, MD Dr. Manera has nothing to disclose.
Ross Zafonte, DO Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MYOMO. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kisbee. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. The institution of Dr. Zafonte has received research support from NIDILRR. The institution of Dr. Zafonte has received research support from NIH. The institution of Dr. Zafonte has received research support from FPHS study. Dr. Zafonte has received publishing royalties from a publication relating to health care.
Lourdes Gomez Romero No disclosure on file
Yasar Zorlu, MD No disclosure on file
Peter A. Abdelmalik, MD No disclosure on file
Sarah Young No disclosure on file
Elliot Graziano No disclosure on file
BEDILE IREM TIFTIKCIOGLU No disclosure on file
Virginija D. Karrenbauer, MD, PhD Dr. Karrenbauer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Yael Hacohen, MBBS Dr. Hacohen has nothing to disclose.
Kathrin LaFaver, MD, FAAN Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. LaFaver has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for WALL, WALL & FRAUENHOFER, LLP. The institution of Dr. LaFaver has received research support from Ayers Foundation. Dr. LaFaver has received publishing royalties from a publication relating to health care. Dr. LaFaver has a non-compensated relationship as a Board Member with FND Society that is relevant to AAN interests or activities. Dr. LaFaver has a non-compensated relationship as a Medical Advisor with FND Hope that is relevant to AAN interests or activities.
Levent Ocek LEVENT OCEK, 4284 has nothing to disclose.
Daniel Gratch No disclosure on file
Xingyao Wu No disclosure on file
Johanna T. Fifi, MD, FAAN Dr. Fifi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker, Inc. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serenity. Dr. Fifi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIVI. Dr. Fifi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Fifi has stock in Endostream. Dr. Fifi has stock in Synchron. Dr. Fifi has stock in Imperative Care. Dr. Fifi has stock in Truvic. Dr. Fifi has stock in Bendit. Dr. Fifi has stock in Cerebrotech. Dr. Fifi has stock in Sim&Cure. Dr. Fifi has stock in Q'Apel. The institution of Dr. Fifi has received research support from Viz AI.
Roberto Cantello No disclosure on file
Andrew Levine No disclosure on file
Wendy Chen, MD Dr. Chen has nothing to disclose.
Sarah Hopkins, MD The institution of Dr. Hopkins has received research support from NIH. The institution of Dr. Hopkins has received research support from CDC.
Alexander Carvajal- Gonzalez, MD, PhD Dr. Carvajal- Gonzalez has nothing to disclose.
Carine W. Maurer, MD, PhD, FAAN Dr. Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. The institution of Dr. Maurer has received research support from Alzheimer's Association & the Foundation of the American Society of Neuroradiology. The institution of Dr. Maurer has received research support from UCB Biopharma SRL. The institution of Dr. Maurer has received research support from Emalex Biosciences. The institution of Dr. Maurer has received research support from Noema Pharma. Dr. Maurer has received publishing royalties from a publication relating to health care.
Juan M. Racosta, MD No disclosure on file
Gunay Gul No disclosure on file
Robert L. Knobler, MD, PhD No disclosure on file
Erika S. Horta, MD Dr. Horta has nothing to disclose.
Ahmed Z. Obeidat, MD, PhD Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/genzyme. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Obeidat has received research support from NIH. The institution of Dr. Obeidat has received research support from NMSS and PCORI. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Speaker with CMSC. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Board of Trustee Member with National MS Society that is relevant to AAN interests or activities.
Elizabeth M. Berry-Kravis, MD, PhD The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren.
Tobias Granberg, MD, PhD The institution of Dr. Granberg has received research support from Karolinska Institutet. The institution of Dr. Granberg has received research support from Region Stockholm. The institution of Dr. Granberg has received research support from Merck. The institution of Dr. Granberg has received research support from Swedish Society for Medical Research.
Tamara M. Pringsheim, MD, FAAN The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Cynthia V. Stack, MD Dr. Stack has nothing to disclose.
Yunhong Bai No disclosure on file
Stanley Tuhrim, MD No disclosure on file
Massimiliano Cristofanilli, PhD No disclosure on file
Elizabeth A. Strong, MD No disclosure on file
Pariwat Thaisetthawatkul, MD, FAAN Dr. Thaisetthawatkul has nothing to disclose.
Jun Shimizu, MD, PhD No disclosure on file
Mahmoud A. AbdelRazek, MD Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. AbdelRazek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics.
Felix Bischof Felix Bischof has nothing to disclose.
Virginia Sturm, PhD Dr. Sturm has nothing to disclose.
Lucas Kipp, MD The institution of Dr. Kipp has received research support from Genentech.
Berge A. Minassian, MD Dr. Minassian has nothing to disclose.
Yuebing Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx.
Jayant N. Acharya, MD, DM, FAAN Dr. Acharya has nothing to disclose.
Rodolfo C. Callejas-Rojas, MD No disclosure on file
Rose M. Sy-Kho, MD No disclosure on file
David Perry, MD The institution of Dr. Perry has received research support from NIH/NIA.
Laura M. Scorr, MD Dr. Scorr has received research support from Dystonia Medical Research Foundation.
Marytery Fajardo, MD No disclosure on file
Rebekah Mannix, MD, MPH No disclosure on file
Kelsey McDermott No disclosure on file
Reyna Duron, MD No disclosure on file
Laura Guilhoto, MD No disclosure on file
Laurel J. Cherian, MD, FAAN The institution of Dr. Cherian has received research support from NIH.
Scott Patten, PhD Dr. Patten has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Canadian Psychiatric Association. Dr. Patten has received publishing royalties from a publication relating to health care.
Joseph Maytal, MD No disclosure on file
Massimiliano Copetti No disclosure on file
Marco Lima No disclosure on file
Shawna M. Cutting, MD, FAAN The institution of Dr. Cutting has received research support from Genentech.
Meiko Maeda, MD, PhD No disclosure on file
Paisith Piriyawat, MD Dr. Piriyawat has nothing to disclose.
Mesude Tutuncu Dr. Tutuncu has nothing to disclose.
James Conners, MD The institution of Dr. Conners has received research support from nih.
Alexander L. Cohen, MD, PhD, FAAN The institution of Dr. Cohen has received research support from NIH. The institution of Dr. Cohen has received research support from Simons Foundation.
Daniel Vardeh, MD No disclosure on file
Rochelle T. Sweis, DO No disclosure on file
Laura K. Stein, MD, MPH The institution of Dr. Stein has received research support from American Heart Association.
Samuel Arnow No disclosure on file
Eun Hye Jeong, MD No disclosure on file
Mohammed Almekhlafi, MD Dr. Almekhlafi has nothing to disclose.
John B. Quealy, MBBS No disclosure on file
Alberto Maud, MD Dr. Maud has nothing to disclose.
Shefali Karkare, MD Dr. Karkare has nothing to disclose.
Justin T. Jordan, MD, MPH, FAAN Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care.
Kyle Rossi, MD No disclosure on file
Jason R. Thonhoff, MD Dr. Thonhoff has nothing to disclose.
Da Marcus T. Silva, MD, PhD No disclosure on file
Jose Pastor-Rueda No disclosure on file
Elizabeth A. Ng, MD, FAAP, FAANEM, FACNS, FAES Dr. Ng has nothing to disclose.
Tamara Strohm, MD Dr. Strohm has nothing to disclose.
Padmaja Vittal, MD, MS Dr. Vittal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie Pharmaceuticals. Dr. Vittal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals .
Licia Grazzi, MD Dr. Grazzi has received personal compensation in the range of $0-$499 for serving as a Consultant for EliLilly. Dr. Grazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan-abbvie.
Marta Radaelli Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Bichun Ouyang Bichum Ouyang has nothing to disclose.
Syndi Seinfeld, DO, FAAN No disclosure on file
Eero Rissanen, MD Dr. Rissanen has received research support from Sigrid Juselius Foundation.
Alaa T. Hijji, MD Dr. Hijji has nothing to disclose.
Francisco J. Varela, MD Dr. Varela has nothing to disclose.
Ewa M. Way, MD Dr. Way has nothing to disclose.
Priyank Khandelwal, MD Dr. Khandelwal has nothing to disclose.
Celia Oreja Guevara Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for viatris. Celia Oreja Guevara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for biogen. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bms. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for jannsen.
Don Mathew, MD No disclosure on file
Gary Ho, MD, PhD The institution of Dr. Ho has received research support from American Parkinson Disease Association. The institution of Dr. Ho has received research support from NINDS.
Aram Zabeti, MD Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Zabeti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Zabeti has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Zabeti has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen . Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG.
Kate T. Brizzi, MD Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Fern Health. Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon.
Ines Gonzalez Ines Gonzalez has nothing to disclose.
Maria Vassilaki, MD, PhD Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC.
Laura M. Seynaeve, MD No disclosure on file
Yiting Yang, MD No disclosure on file
Eric Gutflais, MD No disclosure on file
YuWu Zhao No disclosure on file
Jonathan Gursky, MD Dr. Gursky has nothing to disclose.
Mayur Chalia, MD Dr. Chalia has nothing to disclose.
Sook Young Roh No disclosure on file
Ashkan Mowla, MD, FAAN No disclosure on file
Jeremiah Aakre, MPH Mr. Aakre has nothing to disclose.
Maria J. Bruzzone, MD, FAAN Dr. Bruzzone has nothing to disclose.
Wenjuan Zhang, MD No disclosure on file
Kirsten M. Fiest, PhD No disclosure on file
Lisa D. Ravdin, PhD, ABPP-CN Dr. Ravdin has nothing to disclose.
Inna Keselman, MD, PhD Dr. Keselman has nothing to disclose.
Stefanie Bock No disclosure on file
Jan-Mendelt Tillema, MD Dr. Tillema has nothing to disclose.
Daniel L. Kenney-Jung, MD The institution of Dr. Kenney-Jung has received research support from CFC Foundation. The institution of Dr. Kenney-Jung has received research support from Advanced Medical Electronics/NIH. The institution of Dr. Kenney-Jung has received research support from Bluebird Bio. The institution of Dr. Kenney-Jung has received research support from Rare Disease Foundation.
Nidhi Kapoor, MD, MBBS, FAAN Dr. Kapoor has nothing to disclose.
Marco Pisa, MD Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Ihtesham Qureshi, MD No disclosure on file
Donnie K. Starnes II, MD Dr. Starnes has nothing to disclose.
Nilesh V. Chaudhary, MD, MBBS No disclosure on file
Viet-Huong Nguyen, PharmD, MPH, MS Dr. Nguyen has nothing to disclose.
Michelle K. Lee, MD No disclosure on file
Zaheerud Cheema, MD Dr. Cheema has nothing to disclose.
Niamh Cawley, MD No disclosure on file
Pilar Maria Ferraro, PhD No disclosure on file
Christian Cordano, MD, PhD Dr. Cordano has nothing to disclose.
Irati Zubizarreta No disclosure on file
Marcus Sucksdorff, MD Dr. Sucksdorff has nothing to disclose.
Hyun-soon Jang No disclosure on file
Kyla A. McKay, PhD Dr. McKay has received research support from Canadian Institutes of Health Research. Dr. McKay has received research support from Swedish Research Council for Health, Working Life, and Welfare. Dr. McKay has received research support from ECTRIMS.
Zwade Marshall, MD No disclosure on file
Ariel Dahan No disclosure on file
Natalie Hellmers, NP Ms. Hellmers has nothing to disclose.
Hugo Botha, MD Dr. Botha has received research support from NIH. An immediate family member of Dr. Botha has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Julie McDaniel, MD Dr. McDaniel has nothing to disclose.
Rebecca J. Thompson, MD No disclosure on file
Rwoof A. Reshi, MD Dr. Reshi has nothing to disclose.
Eduardo Hummelgen, MD No disclosure on file
Christopher Benjamin, PhD No disclosure on file
Reza Bavarsad Shahripour, MD Dr. Bavarsad Shahripour has nothing to disclose.
Saba Rammal, MD No disclosure on file
Lana Harder, PhD Dr. Harder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals.
Nicole Gonzales, MD The institution of Dr. Gonzales has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Serena Soleimani, DO Dr. Soleimani has nothing to disclose.
Shemonti Hasan, MD Dr. Hasan has nothing to disclose.
Jorge G. Ortiz-Garcia, MD, FAAN Dr. Ortiz-Garcia has nothing to disclose.
Bakkiam Subbiah, MD No disclosure on file
Sean T. Pauzauskie, MD Dr. Pauzauskie has stock in Neurable. The institution of Dr. Pauzauskie has received research support from Colorado Office of Economic Development and International Trade.
Rebecca Luke, DO Dr. Luke has nothing to disclose.
Inder Puri, MD, MBBS Dr. Puri has nothing to disclose.
Damien Ferguson, MBBS No disclosure on file
Michael Hamer, MD No disclosure on file
Cumara B. O'Carroll, MD, FAAN Dr. O'Carroll has nothing to disclose.
Peter Sguigna, MD Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Sguigna has received research support from Genentech. The institution of Dr. Sguigna has received research support from Clene Nanomedicine. The institution of Dr. Sguigna has received research support from The International Progressive Multiple Sclerosis Alliance through the National Multiple Sclerosis Society. The institution of Dr. Sguigna has received research support from PCORI. The institution of Dr. Sguigna has received research support from DOD/CDMRP. The institution of Dr. Sguigna has received research support from Alexion. Dr. Sguigna has received intellectual property interests from a discovery or technology relating to health care.
Alaaedin Alhomosh, MD No disclosure on file
Khalil Husari, MD The institution of Dr. Husari has received research support from Maryland Innovation Initiative.
Valeria I. Naranjo, MD No disclosure on file
Javier Salas-Puig No disclosure on file
Caitlin Hof, MD No disclosure on file
Thais Armangue, MD Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Marcello A. Oliveira No disclosure on file
Reji Thomas, MD No disclosure on file
Charles C. Windon, MD Dr. Windon has received personal compensation in the range of $0-$499 for serving as a Consultant for LCN Consulting. Dr. Windon has received research support from Alzheimer's Association. Dr. Windon has received personal compensation in the range of $0-$499 for serving as a 好色先生al Material Collaborator with 好色先生.
Andrew P. Huang, MD The institution of Dr. Huang has received research support from 好色先生.
Eric Schmidt, PhD No disclosure on file
Maher Arabi, MD Dr. Arabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin .
Nonita Mittal, MBBS No disclosure on file
Andrew Brown, MD No disclosure on file
Ellen B. Penney, MD No disclosure on file
Ana C. Albuja, MD No disclosure on file
Michael Karras, MD No disclosure on file
Lawrence P. Goldstick, MD Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for emd serono. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for bristol meyers squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TGA therapeutics. The institution of Dr. Goldstick has received research support from biogen. The institution of Dr. Goldstick has received research support from lily. The institution of Dr. Goldstick has received research support from sanofi Aventis genzyme. The institution of Dr. Goldstick has received research support from genetech.
Heinrich Elinzano, MD No disclosure on file
Chih-Chun Lin, MD, PhD No disclosure on file
Gustavo Santo, MD No disclosure on file
Laura A. Adang, MD Dr. Adang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orchard Therapeutics.
Pramod Chopade, MD No disclosure on file
Dhara Murray-Frank, MD Dr. Murray-Frank has nothing to disclose.
Adriana Florez Vargas, MD No disclosure on file
Olga Lekontseva, MD No disclosure on file
Leila Sellami, MD Dr. Sellami has nothing to disclose.
Amy Taylor No disclosure on file
Lucy Honeycutt No disclosure on file
Gloria Ortiz-Guerrero No disclosure on file
Ali Kerro, MD No disclosure on file
Sonal O. Bhatia, MD Dr. Bhatia has nothing to disclose.
Elizabeth A. Coffee, MD The institution of Dr. Coffee has received research support from NIH.
Jonathan C. Edwards, MD Dr. Edwards has received intellectual property interests from a discovery or technology relating to health care.
Mary E. Phelan, BS, C-TAGME No disclosure on file
Ka-wai G. Ho, MD No disclosure on file
Vikram Bhinder, MD No disclosure on file
Jason S. Gill, MD, PhD Dr. Gill has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Elite Medical Experts. The institution of Dr. Gill has received research support from NIH-NINDS.
Rahul H. Rahangdale, MD Dr. Rahangdale has nothing to disclose.
Neha Garg No disclosure on file
Sen Sheng, MD Dr. Sheng has nothing to disclose.
Francesco Gavazzi, MD, MD, PhD The institution of Dr. Gavazzi has received research support from NIH. The institution of Dr. Gavazzi has received research support from NIH, NINDS. The institution of Dr. Gavazzi has received research support from IONIS Pharmaceuticals.
Justine Shults No disclosure on file
Ancil G. Thomas, DM No disclosure on file
Dena Williams, DO Dr. Williams has nothing to disclose.
Rachael Benson, MD No disclosure on file
Sandra Diaz Garcia, PhD No disclosure on file
Michal Obrzut Michal Obrzut has nothing to disclose.
Medha Gudavalli No disclosure on file
Spurthi Surpur, MD Dr. Surpur has nothing to disclose.
Johnathan L. Davis, DO No disclosure on file
Micaela Nannery No disclosure on file
Muhammad Adeel Saleemi, MBBS The institution of Dr. Saleemi has received research support from NIH.
Afra Janarious, MD Dr. Janarious has nothing to disclose.
Ahamed Subir Humyum Kabir No disclosure on file
Danielle Takacs, MD Dr. Takacs has received publishing royalties from a publication relating to health care.
Melisa Kamali-Grigorian, RN No disclosure on file
Saeed Ansari, MD Dr. Ansari has nothing to disclose.
Johanna O'Day No disclosure on file
Neel Mehta, Neel Mehta No disclosure on file
Robert Yao No disclosure on file
larry rubin No disclosure on file
Natalie Neale, MD Dr. Neale has nothing to disclose.
Lisa K. Park No disclosure on file
Cristopher Bragg, PhD No disclosure on file
Fei Wang, PhD Fei Wang, PhD has received personal compensation for serving as an employee of Stoke Therapeutics.